CELL INTELLIGENCE · 肿瘤细胞治疗研究

脐带血来源 CAR-NK 细胞：肿瘤免疫治疗的新兴即用型平台

Umbilical cord blood-derived CAR-NK cells: an emerging off-the-shelf platform for cancer immunotherapy.

Lisocabtagene Maraleucel 在 B 细胞恶性肿瘤中的临床药理学

Clinical Pharmacology of Lisocabtagene Maraleucel in B-cell Malignancies.

用合成细胞因子受体对 T 细胞进行体内工程化改造可实现抗 CD22 CAR-T 细胞的选择性富集和扩增

In vivo engineering of T cells with a synthetic cytokine receptor enables selective enrichment and expansion of anti-CD22 CAR T cells.

基于连接子分辨 dSTORM 显微镜的嵌合抗原受体单分子定量通用工具盒

A universally applicable toolbox for single-molecule quantification of chimeric antigen receptors using linker-resolved dSTORM microscopy.

靶向 BAFF-R 的人源单域抗体 CAR-T 细胞在 B 细胞恶性肿瘤中显示出良好的临床前活性

Human single domain antibody-based CAR-T cells targeting BAFF-R demonstrate promising preclinical activity in B-cell malignancies.

我们开发了一种基于全人源单域抗体构建的新型 BAFF-R CAR-T 细胞产品。

CAR-T 细胞疗法在代表性不足人群中的前景：一项产生假设的 CD19 基因组分析

Perspective for CAR T-Cell Therapy in Underrepresented Populations: A Hypothesis-Generating CD19 Genomic Analysis.

ASTCT 毒性分级系统对成熟 B 细胞恶性肿瘤 CAR-T 治疗后结局的影响

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

CAR-T 细胞的神经毒性遗留：我们身处何方？

The neurotoxic legacy of CAR-T cells: where do we stand?

异基因 HSCT 复发后供者来源干细胞记忆 CAR-T 细胞的独特体内动力学

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse.

一种用于将嵌合抗原受体基因转导至 NK 细胞的无饲养细胞系统

A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells.